2011
HIV, hepatitis B, and hepatitis C in Zambia
Kapembwa KC, Goldman JD, Lakhi S, Banda Y, Bowa K, Vermund SH, Mulenga J, Chama D, H BH. HIV, hepatitis B, and hepatitis C in Zambia. Journal Of Global Infectious Diseases 2011, 3: 269-274. PMID: 21887060, PMCID: PMC3162815, DOI: 10.4103/0974-777x.83534.Peer-Reviewed Original ResearchHepatitis B coinfectionAntiretroviral therapyHepatitis BElevated AST/ALTHepatitis B surface antigenActive hepatitis BART-eligible adultsViral hepatitis coinfectionElevated liver enzymesHepatitis C antibodyHepatitis C infectionAST/ALTTertiary care facilityB surface antigenHCV AbHepatitis coinfectionC infectionHepatitis CHepatitis screeningTertiary hospitalLiver enzymesEpidemiologic dataC antibodyLow prevalenceCare facilities
2008
Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors
Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. International Journal Of Infectious Diseases 2008, 13: 9-19. PMID: 18835208, PMCID: PMC2651958, DOI: 10.1016/j.ijid.2008.06.019.Peer-Reviewed Original ResearchConceptsHepatitis C antibodyHepatitis CHepatitis BRisk factorsAntigen prevalenceHigh burdenC antibodyActive hepatitis BChronic hepatitis CBlood product transfusionHigh-risk subgroupsHigh-risk populationNational prevalence estimatesMode of transmissionWorld's highest burdenUnsafe bloodChronic hepatitisProduct transfusionLiver failurePediatric populationHigh prevalenceHepatocellular carcinomaNeedle usePrevalence estimatesHealthy adults